Company overview - Apomedica

14
Company overview June 2019

Transcript of Company overview - Apomedica

Page 1: Company overview - Apomedica

Company overview June 2019

Page 2: Company overview - Apomedica

Facts

Founded in 1968 by the doctor and

pharmacist Dr. Friedrich Böhm

No. 3 in Austrian

pharmacies (OTC)

Family business with 59

employees

The most comprehensive

phyto-portfolio in Austria

Equity ratio 75%

Revenue €29 million

Page 3: Company overview - Apomedica

Our vision

We are a leading family-owned

pharmaceutical company in

Austria that aims to expand

this leading role in other

European OTC markets.

Page 4: Company overview - Apomedica

Success factor – new launches

The Dr. Böhm® portfolio today comprises a total of 47 products

Page 5: Company overview - Apomedica

Success factor – Recommended by Pharmacies

(Multiple awards, for example IMS Health OTC Mirror)

Highest product quality

Sustainable product innovations

Marketing activities that attract customers to

the pharmacy

Competent sales force

These success factors has led to numerous awards from

Austrian pharmacies and high recommendations

(Multiple awards, for example IMS Health OTC Mirror)

Page 6: Company overview - Apomedica

Success factor – quality

Produced exclusively in Germany, Switzerland and Austria

All products are manufactured according to GMP requirements

(medicines as well as food supplements)

Own product development and no licensing

High quality of raw materials (pharm. Eur. Quality, multiple controls,

safety, microbiology)

Independent formulations, elaborate expensive manufacturing steps

Innovative combinations & effective dosages

Good compliance (dragées, film-coated tablets)

Page 7: Company overview - Apomedica

Main competitor

Sourc

e: IM

S C

onsum

er

Health q

uart

erl

y revie

w

Value AVP (in thousend euros) Growth +/-% previous year

• OTC / HOM / PAC / PECTop 10 manufacturers according to value – MAT 2018/12

78.386

58.554

46.236

36.129 34.297 34.009 31.497 30.104

23.683 22.791

-1,20,1

17,4

1,0

-1,2

3,0 3,5

-2,1

4,8

-0,8

-5,0

0,0

5,0

10,0

15,0

20,0

0

10.000

20.000

30.000

40.000

50.000

60.000

70.000

80.000

90.000

Page 8: Company overview - Apomedica

Sales performance

Source: internal sales figures, sales in millions of euros

8,55 9,0210,06

12,85 13,41 13,4814,65 14,91

16,0516,68

17,71 17,84

19,54 19,720,56 20,97

22,29

24,52

29,3

0

5

10

15

20

25

30

35

2000/01 2001/02 2002/03 2003/04 2004/05 2005/06 2006/07 2007/08 2008/09 2009/10 2010/11 2011/12 2012/13 2013/14 2014/15 2015/16 2016/17 2017/18 2018/19

Page 9: Company overview - Apomedica

House of big brands

Source: internal sales figures in units; business year 2018/19; sales in units per year

Others

148,002

164,943

332,988

785,875

2,501,539

More than 3.9 million

units per year

ALTERNATIVE

Page 10: Company overview - Apomedica

No. 1 – OTC brand in Austria

*Source: IQVIA OTC Offtake MAT 08/2018

Menopause

Urinary tract

Herbal anti-rheumatic drugs

Healthy joints

Digestion

Leading position in the areas *:

Psychological symptoms

Magnesium

Omega 3

Garlic

47 products

Herbal compounds,

Vitamins, minerals

1place

st

Page 11: Company overview - Apomedica

Top 10 Dr. Böhm® Products - Pharmacy sales12 months (Jan 18 – Dec 18)

In TEUR

4.671

3.668

3.296

2.8062.588

2.2002.012 1.983

1.7861.579

37,233,1

21,3

5,4

50,7

32,3

-5,8

81,2

16,2

24,9

-20,0

-10,0

0,0

10,0

20,0

30,0

40,0

50,0

60,0

70,0

80,0

90,0

0

500

1.000

1.500

2.000

2.500

3.000

3.500

4.000

4.500

5.000

Sales AVP MAT/12/2018 Growth +/-% previous year

Page 12: Company overview - Apomedica

Other strong brands

Medical skin care Medicinal products for

coughs and colds

Homeopathic

medicinal products

13 products 9 products 52 products

Page 13: Company overview - Apomedica

Management

Jürgen Schlagbauer

COO

Ruth Fischer

CEO

Executive board

A team of experienced

doctors, pharmacists and

marketing experts –

under the management

of Mag. Ruth Fischer

CommunicationSupply-Chain Management DistributionResearch & Development

Karin KohlfürstAlbert Kompek Christoph Ladenhaufen Ernst Unger

Divisional management

Martin Überhuber

CMO

Gerlinde Schnabel

CFO

Management

Page 14: Company overview - Apomedica

14

“Thank you

for your attention!”